肝细胞癌的治疗策略:目前的进展和未来的前景
Palaniyandi Muthukutty1, Jeong Heo2,3, So Young Yoo1
1Institute of Nanobio Convergence, Pusan National University, Busan 46241, Republic of Korea.
Vaccines
|February 26, 2026
概括
肝细胞癌 (HCC) 治疗是具有挑战性的,因为其复杂性和耐药性. 组合免疫疗法策略在改善肝癌患者的治疗结果方面表现有前途.
科学领域:
- 肝病学和瘤学 肝病学和瘤学
- 免疫疗法研究 免疫疗法研究
- 癌症治疗方法 癌症治疗方法
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
- 由于分子异质性,晚期诊断和治疗耐药性,HCC带来了治疗挑战.
- 一个抑制瘤的微环境限制了当前针对HCC的免疫疗法的疗效.
研究的目的:
- 提供当前HCC治疗策略的全面概述.
- 强调免疫治疗方法在HCC管理中的作用和挑战.
- 讨论临床试验结果和改善HCC治疗的未来方向.
主要方法:
- 关于HCC治疗方式的当前文献的综述.
- 对免疫疗法临床试验数据的批判性评估.
- 对HCC诊断和治疗耐药性的挑战进行分析.
主要成果:
- 由于内在耐药性和免疫抑制瘤微环境,HCC的管理仍然很困难.
- 像免疫检查点封锁这样的新型免疫疗法显示出有限的持久反应.
- 组合免疫疗法策略正在成为克服耐药性的潜在解决方案.
结论:
- 在HCC中有效的免疫控制是复杂的,需要新的治疗策略.
- 组合免疫疗法为提高HCC治疗疗效提供了有希望的途径.
- 未来的研究应该专注于克服耐药机制,以改善HCC的长期疾病控制.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.6K
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
1.9K
相关概念视频
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:49Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K